tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Stock Investors

1,154 Followers
Based on 733,923 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VIR
On average, investors allocate 3.58% of their portfolios to VIR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 733,923 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VIR

0.2%
Last 7
Days
0.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VIR, out of 733,923 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VIR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.03%
$23.41
Increased
2.02%
$10.29
Increased
0.29%
$10.22
Increased
0.56%
$10.13
Opened
<0.01%
$10.04
Based on the activity of 13,826 investors who made their portfolios public
The table shows changes in VIR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VIR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.34%
-0.56%
-2.14%
43.93B
Technology
ChargePoint Holdings
3.99%
-0.74%
-4.14%
783.22M
Consumer Cyclical
Trade Desk
4.70%
-0.21%
-0.64%
42.14B
Technology
Blink Charging Co
5.20%
-0.85%
-5.12%
331.25M
Industrials
Riot Platforms
4.97%
-0.38%
+2.45%
2.82B
Financial
GE Aerospace
5.44%
-0.56%
+3.46%
175.14B
Industrials
Qualcomm
4.92%
-0.27%
-0.11%
210.89B
Technology
Plug Power
5.00%
-0.80%
-4.43%
2.55B
Industrials
XPeng, Inc. ADR
5.32%
-1.27%
-4.87%
7.43B
Consumer Cyclical
Li Auto
5.56%
-1.23%
-4.56%
26.06B
Consumer Cyclical
Based on the activity of 733,923 active portfolios
Open your Smart Portfolio

VIR Investor Analysis

VIR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.3%
of VIR holders
are under 35
Average Segment Performance
Average P/E Ratio20.00
Beta6.11
Dividend Yield5.28%
VIR investors between 35–55

Between 35–55

12.6%
Last 30 days
Holdings Change
50.0%
of VIR holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.45
Beta10.75
Dividend Yield18.14%
VIR investors over 55

Over 55

7.3%
Last 30 days
Holdings Change
40.7%
of VIR holders
are over 55
Average Segment Performance
Average P/E Ratio18.60
Beta3.83
Dividend Yield6.02%
Overview of age group and performance of VIR stock investors
See who invests in VIR according to age group and performance.

FAQ

How many retail Investors hold VIR?
<0.1% of TipRanks' retail investors hold VIR in their portfolios.
    What is VIR Investor Sentiment?
    VIR’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of VIR in the last 7 days?
      ▼ 0.2% of TipRanks' retail investors changed their holding of VIR in the last 7 days.
        What percentage of retail investors changed their holding of VIR in the last 30 days?
        ▼ 0.4% of TipRanks' retail investors changed their holding of VIR in the last 30 days.
          What is the average age of retail investors who hold VIR?
          The average age of VIR Holders is between 35–55.
            What other stocks have VIR investors also bought?
            VIR Investors also bought SQ, CHPT, TTD, BLNK, RIOT, GE, QCOM, PLUG, XPEV, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis